2018
DOI: 10.1016/j.brainres.2017.10.027
|View full text |Cite
|
Sign up to set email alerts
|

Sialic acid and anti-ganglioside antibody levels in children with autism spectrum disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
20
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 29 publications
3
20
0
Order By: Relevance
“…Anti-GM1 antibodies have been described in motor neuropathies, but also in neurodegenerative diseases such as GM1 gangliosidosis, multifocal motor neuropathy, dementia and Guillain-Barré syndrome (113116). Two studies have reported increased levels of these antibodies in ASD patients using ELISA, however with widely different sensitivities, varying from 74 to 38%, and corresponding specificities of 95 and 78%, respectively (Table 1) (46, 47). Moreover, in the study by Mostafa et al (46), a significant correlation with disease severity was found, whereas this could not be confirmed in another study (47).…”
Section: Autoantibodies In Asd Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…Anti-GM1 antibodies have been described in motor neuropathies, but also in neurodegenerative diseases such as GM1 gangliosidosis, multifocal motor neuropathy, dementia and Guillain-Barré syndrome (113116). Two studies have reported increased levels of these antibodies in ASD patients using ELISA, however with widely different sensitivities, varying from 74 to 38%, and corresponding specificities of 95 and 78%, respectively (Table 1) (46, 47). Moreover, in the study by Mostafa et al (46), a significant correlation with disease severity was found, whereas this could not be confirmed in another study (47).…”
Section: Autoantibodies In Asd Patientsmentioning
confidence: 99%
“…Two studies have reported increased levels of these antibodies in ASD patients using ELISA, however with widely different sensitivities, varying from 74 to 38%, and corresponding specificities of 95 and 78%, respectively (Table 1) (46, 47). Moreover, in the study by Mostafa et al (46), a significant correlation with disease severity was found, whereas this could not be confirmed in another study (47). Nevertheless, it seems that anti-GM1 antibodies have been associated with ASD, but their specific role remains to be elucidated.…”
Section: Autoantibodies In Asd Patientsmentioning
confidence: 99%
“…To our knowledge, there was only one study investigating the relationship between plasma Sia levels and the pathogenesis of ASD in humans. They found that the level of plasma Sia in the control group higher than that in the children with ASD 14). Also, in 2014, a child diagnosed with ASD and epilepsy was found to have a heterozygous 520-kb deletion on chromosome 15q26.1, where ST8SIA2 is located 15).…”
Section: Introductionmentioning
confidence: 99%
“…A more recent GWAS also revealed a relationship between increased expression of a ST3GAL3 transcript in the human fetal brain and a risk for ADHD and schizophrenia ( Hall et al., 2020 ). Moreover, children with ASD often displayed increased anti-ganglioside antibody levels ( Mostafa and Al-Ayadhi, 2011 ; Yang et al., 2018 ) and changes in the ganglioside expression has also been proposed as a biomarker for schizophrenia ( Sarbu et al., 2018 ).…”
Section: Introductionmentioning
confidence: 99%